<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pntd.0006822.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pntd.0006822.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>Example epidemiologicalâˆ’entomological parameters intended to demonstrate public health value of a new vector-control tool
   <xref ref-type="table-fn" rid="t001fn001">
    <sup>1</sup>
   </xref>.
  </title>
 </caption>
 <alternatives>
  <graphic id="pntd.0006822.t001g" xlink:href="pntd.0006822.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Parameters</th>
     <th align="left" rowspan="1" colspan="1">Requirements</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">Epidemiology</td>
     <td align="left" rowspan="1" colspan="1">A significant reduction in incidence of pathogen infections compared to control using randomized cluster trial. Level of compliance and coverage required in relation to efficacy detected.</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Entomology</td>
     <td align="left" rowspan="1" colspan="1">Trends indicating significantly reduced vector population density, longevity/population age structure (parity rates), and/or arbovirus infection over time between treatment arms.</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Economics</td>
     <td align="left" rowspan="1" colspan="1">Projected cost per unit protected similar to, or less than, currently deployed arbovirus vector-control strategy in trial setting.</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Technology development</td>
     <td align="left" rowspan="1" colspan="1">Prototype or product is essentially ready to manufacture at scale; may require minor changes to improve the method in response to trial outcomes.</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Manufacturability sustainability</td>
     <td align="left" rowspan="1" colspan="1">Confirmation of commercial sustainability by manufacturer/producer; early manufacturing/production runs at volume; intellectual property issues resolved and commercial production possible. Product procurements and pre- and post-marketing QA</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">User compliance/acceptability</td>
     <td align="left" rowspan="1" colspan="1">User acceptability/compliance estimated.</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Delivery and feasibility of implementation</td>
     <td align="left" rowspan="1" colspan="1">Feasibility of intervention implementation demonstrated.</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Regulatory/safety/ethical and environmental impact</td>
     <td align="left" rowspan="1" colspan="1">Adverse events monitored during trial; registration of product.</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>
    <sup>1</sup>Adapted from the WHO VCAG (
    <ext-link ext-link-type="uri" xlink:href="http://www.who.int/neglected_diseases/vector_ecology/Operational_procedures_for_VCAG.pdf?ua=1" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.who.int/neglected_diseases/vector_ecology/Operational_procedures_for_VCAG.pdf?ua=1</ext-link>)
   </p>
  </fn>
  <fn id="t001fn002">
   <p>
    <bold>Abbreviations:</bold> QA, quality assurance; VCAG, Vector Control Advisory Group; WHO, World Health Organization.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
